Zobrazeno 1 - 10
of 385
pro vyhledávání: '"Bevan Jones, WR"'
Autor:
Strauss A; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, UK., Swann P; Department of Psychiatry, University of Cambridge, Cambridge, UK., Kigar SL; Department of Psychiatry, University of Cambridge, Cambridge, UK.; Department of Medicine, University Cambridge, Cambridge, UK., Christou R; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, UK., Savinykh Yarkoni N; Department of Medicine, University Cambridge, Cambridge, UK., Turner L; Department of Psychiatry, University of Cambridge, Cambridge, UK.; Department of Medicine, University Cambridge, Cambridge, UK., Murley AG; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, UK., Chouliaras L; Department of Psychiatry, University of Cambridge, Cambridge, UK., Shapiro N; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, UK., Ashton NJ; Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden.; Banner Alzheimer's Institute and University of Arizona, Phoenix, AZ, USA.; Banner Sun Health Research Institute, Sun City, AZ, USA., Savulich G; Department of Psychiatry, University of Cambridge, Cambridge, UK., Bevan-Jones WR; Department of Psychiatry, University of Cambridge, Cambridge, UK., Surendranthan A; Department of Psychiatry, University of Cambridge, Cambridge, UK., Blennow K; Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden., Zetterberg H; Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., O'Brien JT; Department of Psychiatry, University of Cambridge, Cambridge, UK., Rowe JB; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK., Malpetti M; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, UK. mm2243@medschl.cam.ac.uk.; UK Dementia Research Institute at University of Cambridge, Cambridge, UK. mm2243@medschl.cam.ac.uk.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2024 Oct 29. Date of Electronic Publication: 2024 Oct 29.
Autor:
Malpetti M; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., Swann P; Department of Psychiatry, University of Cambridge, Cambridge, CB2 0QQ, UK., Tsvetanov KA; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK.; Department of Psychology, University of Cambridge, Cambridge, CB2 3EB, UK., Chouliaras L; Department of Psychiatry, University of Cambridge, Cambridge, CB2 0QQ, UK., Strauss A; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., Chikaura T; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., Murley AG; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Wallenberg Centre for Molecular Medicine, University of Gothenburg, Gothenburg, S-413 45, Sweden.; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, SE5 9RT, UK.; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, SE5 8AF, UK., Barker P; NIHR Cambridge Biomedical Research Centre, Core BiochemicalAssay Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK., Jones PS; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., Fryer TD; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., Hong YT; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., Cope TE; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK., Savulich G; Department of Psychiatry, University of Cambridge, Cambridge, CB2 0QQ, UK., Street D; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., Bevan-Jones WR; Department of Psychiatry, University of Cambridge, Cambridge, CB2 0QQ, UK., Rittman T; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, S-431 80, Sweden., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, S-431 80, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 6BG, UK.; UK Dementia Research Institute at UCL, London, WC1N 6BG, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA., Aigbirhio FI; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK., O'Brien JT; Department of Psychiatry, University of Cambridge, Cambridge, CB2 0QQ, UK., Rowe JB; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 0SZ, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.
Publikováno v:
Brain : a journal of neurology [Brain] 2024 Aug 19. Date of Electronic Publication: 2024 Aug 19.
Autor:
Street D; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK., Bevan-Jones WR; Department of Psychiatry, University of Cambridge, UK., Malpetti M; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK., Jones PS; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK., Passamonti L; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK; Consiglio Nazionale Delle Ricerche (CNR), Istituto di Bioimmagini e Fisiologia Molecolare (IBFM), Milano, Italy., Ghosh BC; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK; Wessex Neurological Centre, University Hospitals Southampton NHS Foundation Trust, Southampton, UK., Rittman T; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK., Coyle-Gilchrist IT; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK; Norfolk and Norwich NHS Foundation Trust, Norwich, UK., Allinson K; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK; Department of Pathology, Cambridge University Hospitals NHS Trust, Cambridge, UK., Dawson CE; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK., Rowe JB; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK. Electronic address: james.rowe@mrc-cbu.cam.ac.uk.
Publikováno v:
Parkinsonism & related disorders [Parkinsonism Relat Disord] 2023 Nov; Vol. 116, pp. 105866. Date of Electronic Publication: 2023 Oct 02.
Autor:
Malpetti M; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Cope TE; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK., Street D; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Jones PS; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Hezemans FH; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK., Mak E; Department of Psychiatry, University of Cambridge, Cambridge CB2 0QQ, UK., Tsvetanov KA; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Rittman T; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Bevan-Jones WR; Department of Psychiatry, University of Cambridge, Cambridge CB2 0QQ, UK., Patterson K; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK., Passamonti L; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Fryer TD; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge CB2 0QQ, UK., Hong YT; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge CB2 0QQ, UK., Aigbirhio FI; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge CB2 0QQ, UK., O'Brien JT; Department of Psychiatry, University of Cambridge, Cambridge CB2 0QQ, UK., Rowe JB; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK.
Publikováno v:
Brain : a journal of neurology [Brain] 2023 Aug 01; Vol. 146 (8), pp. 3221-3231.
Autor:
Adams NE; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK., Jafarian A; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Perry A; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK., Rouse MA; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK., Shaw AD; Washington Singer Laboratories, University of Exeter, Exeter EX4 4QG, UK., Murley AG; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Cope TE; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK., Bevan-Jones WR; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Passamonti L; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK., Street D; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Holland N; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Nesbitt D; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK., Hughes LE; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK., Friston KJ; Wellcome Centre for Human Neuroimaging, University College London, London WC1N 3AR, UK., Rowe JB; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge CB2 0SZ, UK.; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK.
Publikováno v:
Brain : a journal of neurology [Brain] 2023 Jun 01; Vol. 146 (6), pp. 2584-2594.
Autor:
Passamonti L 1, Rodríguez PV 2, Hong YT 2, Allinson KSJ 2, Bevan-Jones WR 2, Williamson D 2, Jones PS 2, Arnold R 2, Borchert RJ 2, Surendranathan A 2, Mak E 2, Su L 2, Fryer TD 2, Aigbirhio FI 2, O'Brien JT 2, Rowe JB 2.
Publikováno v:
Neurology 90 (2018): e1989–e1996. doi:10.1212/WNL.0000000000005610
info:cnr-pdr/source/autori:Passamonti L 1, Rodríguez PV 2, Hong YT 2, Allinson KSJ 2, Bevan-Jones WR 2, Williamson D 2, Jones PS 2, Arnold R 2, Borchert RJ 2, Surendranathan A 2, Mak E 2, Su L 2, Fryer TD 2, Aigbirhio FI 2, O'Brien JT 2, Rowe JB 2./titolo:[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy./doi:10.1212%2FWNL.0000000000005610/rivista:Neurology/anno:2018/pagina_da:e1989/pagina_a:e1996/intervallo_pagine:e1989–e1996/volume:90
info:cnr-pdr/source/autori:Passamonti L 1, Rodríguez PV 2, Hong YT 2, Allinson KSJ 2, Bevan-Jones WR 2, Williamson D 2, Jones PS 2, Arnold R 2, Borchert RJ 2, Surendranathan A 2, Mak E 2, Su L 2, Fryer TD 2, Aigbirhio FI 2, O'Brien JT 2, Rowe JB 2./titolo:[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy./doi:10.1212%2FWNL.0000000000005610/rivista:Neurology/anno:2018/pagina_da:e1989/pagina_a:e1996/intervallo_pagine:e1989–e1996/volume:90
OBJECTIVE: We tested whether in vivo neuroinflammation relates to the distinctive distributions of pathology in Alzheimer disease (AD) and progressive supranuclear palsy (PSP). METHODS: Sixteen patients with symptomatic AD (including amnestic mild co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::7f7f925914cc02d6ee8075a7ea4b5ff3
Autor:
Mak, FK, Gabel, S, Su, L, Williams, GB, Arnold, R, Passamonti, L, Vazquez Rodríguez, P, Surendranathan, A, Bevan-Jones, WR, Rowe, JB, O'Brien, JT
Publikováno v:
International Psychogeriatrics
$\textbf{BACKGROUND}$: Volumetric atrophy and microstructural alterations in diffusion tensor imaging (DTI) measures of the hippocampus have been reported in people with Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, no study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b62b6d199f5534faf68a2a836b9ef0b8
http://europepmc.org/articles/PMC5819731
http://europepmc.org/articles/PMC5819731
Autor:
Malpetti M; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom; mm2243@medschl.cam.ac.uk., Kaalund SS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Tsvetanov KA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Rittman T; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Briggs M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Cambridge University Brain Bank, Cambridge, United Kingdom., Allinson KSJ; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Cambridge University Brain Bank, Cambridge, United Kingdom., Passamonti L; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Istituto di Bioimmagini e Fisiologia Molecolare (IBFM), Consiglio Nazionale delle Ricerche (CNR), Milano, Italy., Holland N; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Jones PS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Fryer TD; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, United Kingdom., Hong YT; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, United Kingdom., Kouli A; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Bevan-Jones WR; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; and., Mak E; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; and., Savulich G; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; and., Spillantini MG; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Aigbirhio FI; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, United Kingdom., Williams-Gray CH; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., O'Brien JT; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; and., Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Jul; Vol. 63 (7), pp. 1052-1057. Date of Electronic Publication: 2021 Nov 18.
Autor:
Bevan Jones, WR, Cope, Thomas, Passamonti, Luca, Fryer, Timothy, Hong, Young, Aigbirhio, Franklin, Kril, JJ, Forrest, SL, Allinson, K, Coles, Jonathan, Simon Jones, P, Spillantini, Maria, Hodges, O'Brien, John, Rowe, James
The validation of tau radioligands could improve the diagnosis of frontotemporal lobar degeneration and the assessment of disease-modifying therapies. Here, we demonstrate that binding of the tau radioligand [18F]AV-1451 was significantly abnormal in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b29f62c829f679ddcb51538b0c7ad53
Autor:
Adams NE; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK., Hughes LE; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK.; MMRC Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK., Rouse MA; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK., Phillips HN; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK., Shaw AD; MMRC Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK., Murley AG; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK.; Cambridge University Hospitals, Cambridge, CB2 0QQ, UK., Cope TE; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK.; MMRC Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK.; Cambridge University Hospitals, Cambridge, CB2 0QQ, UK., Bevan-Jones WR; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK.; Cambridge University Hospitals, Cambridge, CB2 0QQ, UK., Passamonti L; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK.; Cambridge University Hospitals, Cambridge, CB2 0QQ, UK., Street D; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK.; Cambridge University Hospitals, Cambridge, CB2 0QQ, UK., Holland N; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK.; Cambridge University Hospitals, Cambridge, CB2 0QQ, UK., Nesbitt D; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK.; MMRC Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK.; Cambridge University Hospitals, Cambridge, CB2 0QQ, UK., Friston K; Wellcome Centre for Human Neuroimaging, University College London, London WC1N 3AR, UK., Rowe JB; Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0QQ, UK.; MMRC Cognition and Brain Sciences Unit, Cambridge CB2 7EF, UK.; Cambridge University Hospitals, Cambridge, CB2 0QQ, UK.
Publikováno v:
Brain : a journal of neurology [Brain] 2021 Aug 17; Vol. 144 (7), pp. 2135-2145.